BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7582299)

  • 1. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease.
    Maeda J; Ueki N; Hada T; Higashino K
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1587-91. PubMed ID: 7582299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients.
    Takigawa N; Segawa Y; Maeda Y; Takata I; Fujimoto N
    Lung Cancer; 1997 Jul; 17(2-3):211-8. PubMed ID: 9237156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hepatocyte growth factor levels in patients with inflammatory lung diseases.
    Huang MS; Tsai MS; Wang TH; Chong IW; Hou JJ; Lin YJ; Hwang JJ
    Kaohsiung J Med Sci; 1999 Apr; 15(4):195-201. PubMed ID: 10330798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
    Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
    J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H; Li Q; Zaide W; Yunde H
    In Vivo; 1999; 13(2):177-80. PubMed ID: 10363175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
    Humphrey PA; Halabi S; Picus J; Sanford B; Vogelzang NJ; Small EJ; Kantoff PW
    Clin Genitourin Cancer; 2006 Mar; 4(4):269-74. PubMed ID: 16729910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of hepatocyte growth factor/scatter factor (HGF/SF) in seminal plasma of patients with andrological diseases.
    Depuydt CE; De Potter CR; Zalata A; Baekelandt E; Bosmans E; Comhaire FH
    J Androl; 1998; 19(2):175-82. PubMed ID: 9570740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of lung-transplant rejection by hepatocyte growth factor.
    Aharinejad S; Taghavi S; Klepetko W; Abraham D
    Lancet; 2004 May; 363(9420):1503-8. PubMed ID: 15135596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism.
    Sugihara G; Hashimoto K; Iwata Y; Nakamura K; Tsujii M; Tsuchiya KJ; Sekine Y; Suzuki K; Suda S; Matsuzaki H; Kawai M; Minabe Y; Yagi A; Takei N; Sugiyama T; Mori N
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):412-5. PubMed ID: 17157424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor (HGF) in patients with pneumonia: a comparison between survivors and non-survivors.
    Nayeri F; Nilsson I; Skude G; Brudin L; Söderström C
    Scand J Infect Dis; 1998; 30(4):405-9. PubMed ID: 9817523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of hepatocyte growth factor/scatter factor in patients with liver metastases from breast cancer.
    Eichbaum MH; de Rossi TM; Kaul S; Bruckner T; Schneeweiss A; Sohn C
    Tumour Biol; 2007; 28(1):36-44. PubMed ID: 17143015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes of serum hepatocyte growth factor in coronary artery disease].
    Suzuki H; Murakami M; Kondo T; Shibata M; Ezumi H; Okabayashi H; Yorozuya M; Makishima N; Hamazaki Y; Nakatani M; Namiki A; Katagiri T
    J Cardiol; 2000 May; 35(5):319-24. PubMed ID: 10834175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
    Briggs MC; Grierson I; Hiscott P; Hunt JA
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.
    Ozden M; Kalkan A; Demirdag K; Denk A; Kilic SS
    J Infect; 2004 Oct; 49(3):229-35. PubMed ID: 15337340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
    Vejchapipat P; Tangkijvanich P; Theamboonlers A; Chongsrisawat V; Chittmittrapap S; Poovorawan Y
    J Gastroenterol; 2004 Dec; 39(12):1182-8. PubMed ID: 15622483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination and clinical significance of human hepatocyte growth factor in serum].
    Takemura M; Furuta N; Nakamura S; Okuno M; Seishima M; Noma A; Sugihara J; Murakami N; Sugiyama H; Moriwaki H
    Rinsho Byori; 1992 Nov; 40(11):1168-72. PubMed ID: 1307623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
    Shiota G; Okano J; Kawasaki H; Kawamoto T; Nakamura T
    Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
    Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.